Skip to main content
SpringerLink
Log in

Prevalence of hepatitis B and C viruses infection in chronic alcoholics with or without liver disease in Ioannina, Greece: Low incidence of HCV infection

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Intravenous heroin abusers comprise a high risk group for hepatitis B and C viruses (HBV and HCV) infection. Chronic alcoholics with liver disease (LD) also comprise a high risk group for HBV infection whereas the frequency of antibodies to HCV (anti-HCV) ranges from 27–42.6%. In this study, HBV and HCV infection markers were determined in alcoholic patients with (83 patients) or without LD (68 patients) in order to assess the prevalence of these markers (HBsAg, HBsAb, HBcAb and anti-HCV). The reason for the study was a lack of established data in this group of patients in Greece. The disease control groups consisted of 70 non-alcoholic hospitalized patients and 60 heroin addicts, whereas 1342 healthy blood donors were also investigated. Our results showed significantly increased prevalence of HBV infection markers in chronic alcoholic patients compared to healthy controls and non-alcoholic hospitalized patients. The findings were independent of the presence or absence of LD. In contrast to heroin addicts, where anti-HCV antibodies were observed in 90%, there was no difference in the prevalence of anti-HCV antibodies in chronic alcoholics (with or without LD), nonalcoholic hospitalized patients or healthy controls. In conclusion, we found that in this area of northwestern Greece, chronic alcoholics, independent of the presence of LD, comprise a high risk group for HBV infection but very rarely have HCV infection. The latter finding may reflect technical or socioeconomic differences regarding the lifestyle of our patients, and our population in general.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pittigrew NM, Goudie RB, Russel RI, Chaudhuri AKR. Evidence of a role of hepatitis B virus in chronic liver disease. Lancet 1972 (i): 725–728.

  2. Omata M, Afroudakis A, Liew CT, et al. Comparison of serum hepatitis B surface antigen and serum anticore with tissue HBsAg and hepatitis B core antigen (HBcAg). Gastroenterology 1978; 75: 1003–1009.

    Google Scholar 

  3. Mills PR, Follet EAC, Urquhart GED, et al. Evidence for previous hepatitis B virus infection in alcoholic cirrhosis. Br Med J 1981; 282: 437–438.

    Google Scholar 

  4. Basile A, Vitale G, Macor C. Hepatitis B virus infection in alcoholic cirrhosis. Br Med J 1981; 282: 1705.

    Google Scholar 

  5. Blum HE, Offensperger WB, Walter E, et al. Hepatitis B virus DNA in chronic liver disease. N Engl J Med 1987; 317: 116–117.

    Google Scholar 

  6. Brechot C, Nalpas B, Courouce AM, et al. Evidence that hepatitis B virus has a role in liver-cell carcinoma in alcoholic liver disease. N Engl J Med 1982; 306: 1384–1387.

    Google Scholar 

  7. Gluud C, Gluud B, Aldershvile J, et al. Prevalence of hepatitis B virus infection in out-patient alcoholics. Infection 1984; 12: 72–74.

    Google Scholar 

  8. Fong TL, Govindarajan S, Valinluck B, Redeker AG. Status of hepatitis B virus DNA in alcoholic liver disease: A study of large urban population in the United States. Hepatology 1988; 8: 1602–1604.

    Google Scholar 

  9. Mendenhall CL, Seeff L, Diehl AM, et al. Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: Their prevalence and clinical relevance. Hepatology 1991; 14: 581–589.

    Google Scholar 

  10. Bruix J, Barrera JM, Calvet X, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989 (ii): 1004–1006.

    Google Scholar 

  11. Pares A, Barrera JM, Caballeria J, et al. Hepatitis C virus antibodies in chronic alcoholic patients: Association with severity of liver injury. Hepatology 1990; 12: 1295–1299.

    Google Scholar 

  12. Brillanti S, Barbara L, Miglioli M, Bonino F. Hepatitis C virus: A possible cause of chronic hepatitis in alcoholics. Lancet 1989 (ii): 1390–1391.

    Google Scholar 

  13. Review by an International Group. Alcoholic liver disease: Morphologic manifestations. Lancet 1981 (i): 707–711.

    Google Scholar 

  14. Dalekos GN, Manoussakis MN, Zervou E, et al. Immunologic and viral markers in the circulation of anti-HIV negative heroin addicts. Eur J Clin Invest 1993; 23: 219–225.

    Google Scholar 

  15. Van der Poel CL, Cuypers HTM, Reesink HW, et al. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 1991; 337: 317–319.

    Google Scholar 

  16. Szmuness W. Recent advances in the study of epidemiology of hepatitis B. Am J Pathol 1975; 81: 629–650.

    Google Scholar 

  17. Dalekos GN, Zervou E, Karabini F, Tsianos EV. Prevalence of viral markers among refugees from southern Albania: Increased incidence of infection with hepatitis A, B, and D viruses. Eur J Gastroenterol Hepatol 1995; 7: 553–558.

    Google Scholar 

  18. Tsianos EV, Dalekos GN, Elisaf M, et al. High frequency of antibodies to Hantaan virus and hepatitis C virus in haemodialysis patients: Coincidence or cross reaction? J Intern Med 1993; 234: 607–610.

    Google Scholar 

  19. Elisaf M, Tsianos E, Mavridis A, et al. Antibodies against hepatitis C virus (anti-HCV) in haemodialysis patients: Association with hepatitis B serological markers. Nephrol Dial Transpl 1991; 6: 476–479.

    Google Scholar 

  20. Papatheodoridis GV, Delladetsima I, Koutelou M, et al. Prevalence of antibodies to hepatitis C virus in Greek patients with chronic liver disease. J Hepatol 1994; 20: 311 (Letter).

    Google Scholar 

  21. Kuo G, Choo Q-L, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 359–361.

    Google Scholar 

  22. Wilson ID, Onstad G, Williams Jr RC. Serum immunoglobulin concentrations in patients with alcoholic liver disease. Gastronterology 1969; 57: 59–67.

    Google Scholar 

  23. Haukenes G, Matre R, Tonder O, et al. Measles and rubella antibodies in patients with chronic liver disease. J Hepatol 1990; 11: 389 (Letter).

    Google Scholar 

  24. Mendenhall CL, Roselle GA, Grossman CJ, et al. False positive tests for HTLV-III antibodies in alcoholic patients with hepatitis. N Eng J Med 1986; 314: 921–922 (Letter).

    Google Scholar 

  25. Choo Q-L, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-born non-A, non-B viral hepatitis genome. Science 1989; 244: 362–364.

    Google Scholar 

  26. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 327: 1899–1905.

    Google Scholar 

  27. Alter MJ, Hadler SC, Judson FN, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus antibody. JAMA 1990; 264: 2231–2235.

    Google Scholar 

  28. Esteban JI, Viladomiu L, Gonzalez A, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989 (ii): 294–297.

    Google Scholar 

  29. Hess G, Massing A, Rossol S, et al. Hepatitis C Virus and sexual transmission. Lancet 1989 (ii): 987.

    Google Scholar 

  30. Drosos AA, Lanchbury JS, Panayi GS, Moutsopoulos HM. Rheumatoid arthritis in Greek and British patients. A comparative clinical, radiologic and serologic study. Arthritis Rheum 1992; 35: 745–748.

    Google Scholar 

  31. Tsianos EV, Masalas CN, Merkouropoulos MH, et al. Incidence of inflammatory bowel disease in north west Greece: Rarity of Crohn's disease in an area where ulcerative colitis is common. Gut 1994; 35: 369–372.

    Google Scholar 

  32. Tsianos EV, Dalekos GN, Merkouropoulos MH, et al. Frequency of thyroid dysfunction after recombinant alpha interferon therapy in Greek patients with chronic active hepatitis. Eur J Gastroenterol Hepatol 1994; 6: 547–551.

    Google Scholar 

  33. Dalekos GN, Zervou E, Tsianos EV. IgM antibodies to hepatitis C virus in chronic active hepatitis C in NW Greece. Solution or more questions? J Hepatol 1995; 22: 509 (Letter).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine (Hepato-Gastroenterology Division), School of Medicine, University of Ioannina, Ioannina

    Georgios N. Dalekos, Markos H. Merkouropoulos & Epameinondas V. Tsianos

  2. Blood Bank at the University Hospital of Ioannina, Greece

    Eleftheria Zervou

Authors
  1. Georgios N. Dalekos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eleftheria Zervou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Markos H. Merkouropoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Epameinondas V. Tsianos
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dalekos, G.N., Zervou, E., Merkouropoulos, M.H. et al. Prevalence of hepatitis B and C viruses infection in chronic alcoholics with or without liver disease in Ioannina, Greece: Low incidence of HCV infection. Eur J Epidemiol 12, 21–25 (1996). https://doi.org/10.1007/BF00144423

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00144423

Key words

Search

Navigation